Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Robert J. Kreitman, Evgeny Arons et al.|Journal of Clinical Oncology|2020Cited by 104
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Robert J. Kreitman, Irina Marić et al.|Blood Advances|2021Cited by 28
Expression of the muscle-associated gene MYF6 in hairy cell leukemiaEvgeny Arons, Robert J. Kreitman, Hong Zhou et al.|PLoS ONE|2020Cited by 8
COVID-19 in patients with classic and variant hairy cell leukemiaRobert J. Kreitman, Evgeny Arons, Theresa Yu et al.|Blood Advances|2023Cited by 5
Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia VariantDai Chihara, Robert J. Kreitman, Evgeny Arons et al.|Blood|2019Cited by 3